Less sclerotic microarchitecture pattern with increased bone resorption in glucocorticoid-associated osteonecrosis of femoral head as compared to alcohol-associated osteonecrosis of femoral head.
alcohol
bone histopathology
bone microstructure
bone remodeling
glucocorticoid
micro-computed tomography
osteonecrosis of the femoral head
Journal
Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782
Informations de publication
Date de publication:
2023
2023
Historique:
received:
29
12
2022
accepted:
13
02
2023
medline:
28
3
2023
entrez:
27
3
2023
pubmed:
28
3
2023
Statut:
epublish
Résumé
Glucocorticoid usage and alcohol abuse are the most widely accepted risk factors for nontraumatic osteonecrosis of femoral head (ONFH). Despite distinct etiologies between glucocorticoid-associated ONFH (GONFH) and alcohol-associated ONFH (AONFH), little is known about the differences of the microarchitectural and histomorphologic characteristics between these subtypes of ONFH. To investigate bone microarchitecture, bone remodeling activity and histomorphology characteristics of different regions in femoral heads between GONFH and AONFH. From September 2015 to October 2020, 85 patients diagnosed with GONFH and AONFH were recruited. Femoral heads were obtained after total hip replacement. Femoral head specimens were obtained from 42 patients (50 hips) with GONFH and 43 patients (50 hips) with AONFH. Micro-CT was utilized to assess the microstructure of 9 regions of interest (ROIs) in the femoral head. Along the supero-inferior orientation, the femoral head was divided into necrotic region, reactive interface, and normal region; along the medio-lateral orientation, the femoral head was divided into medial region, central region and lateral region. Decalcified and undecalcified bone histology was subsequently performed to evaluate histopathological alterations and bone remodeling levels. In the necrotic region, most of the microarchitectural parameters did not differ significantly between GONFH and AONFH, whereas both the reactive interface and normal region revealed a less sclerotic microarchitecture but a higher bone remodeling level in GONFH than AONFH. Despite similar necrotic pathological manifestations, subchondral trabecular microfracture in the necrotic region was more severe and vasculature of the reactive interface was more abundant in GONFH. GONFH and AONFH shared similar microarchitecture and histopathological features in the necrotic region, while GONFH exhibited a less sclerotic microarchitecture and a more active bone metabolic status in both the reactive interface and normal region. These differences between GONFH and AONFH in bone microarchitectural and histopathological characteristics might contribute to the development of disease-modifying prevention strategies and treatments for ONFH, taking into etiologies.
Sections du résumé
Background
Glucocorticoid usage and alcohol abuse are the most widely accepted risk factors for nontraumatic osteonecrosis of femoral head (ONFH). Despite distinct etiologies between glucocorticoid-associated ONFH (GONFH) and alcohol-associated ONFH (AONFH), little is known about the differences of the microarchitectural and histomorphologic characteristics between these subtypes of ONFH.
Purposes
To investigate bone microarchitecture, bone remodeling activity and histomorphology characteristics of different regions in femoral heads between GONFH and AONFH.
Methods
From September 2015 to October 2020, 85 patients diagnosed with GONFH and AONFH were recruited. Femoral heads were obtained after total hip replacement. Femoral head specimens were obtained from 42 patients (50 hips) with GONFH and 43 patients (50 hips) with AONFH. Micro-CT was utilized to assess the microstructure of 9 regions of interest (ROIs) in the femoral head. Along the supero-inferior orientation, the femoral head was divided into necrotic region, reactive interface, and normal region; along the medio-lateral orientation, the femoral head was divided into medial region, central region and lateral region. Decalcified and undecalcified bone histology was subsequently performed to evaluate histopathological alterations and bone remodeling levels.
Results
In the necrotic region, most of the microarchitectural parameters did not differ significantly between GONFH and AONFH, whereas both the reactive interface and normal region revealed a less sclerotic microarchitecture but a higher bone remodeling level in GONFH than AONFH. Despite similar necrotic pathological manifestations, subchondral trabecular microfracture in the necrotic region was more severe and vasculature of the reactive interface was more abundant in GONFH.
Conclusions
GONFH and AONFH shared similar microarchitecture and histopathological features in the necrotic region, while GONFH exhibited a less sclerotic microarchitecture and a more active bone metabolic status in both the reactive interface and normal region. These differences between GONFH and AONFH in bone microarchitectural and histopathological characteristics might contribute to the development of disease-modifying prevention strategies and treatments for ONFH, taking into etiologies.
Identifiants
pubmed: 36967755
doi: 10.3389/fendo.2023.1133674
pmc: PMC10031038
doi:
Substances chimiques
Glucocorticoids
0
Ethanol
3K9958V90M
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1133674Informations de copyright
Copyright © 2023 Chen, Miao, Liu, Zhu, Xue, Yin, Zou, Li, Zhang and Feng.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Orthop Surg. 2021 Oct;13(7):2043-2050
pubmed: 34585838
Sci Rep. 2017 Oct 17;7(1):13345
pubmed: 29042586
Int J Biol Sci. 2017 Apr 7;13(4):480-491
pubmed: 28529456
J Korean Med Sci. 2021 Mar 15;36(10):e65
pubmed: 33724736
J Arthroplasty. 2020 Apr;35(4):933-940
pubmed: 31866252
Chin Med J (Engl). 2015 Nov 5;128(21):2843-50
pubmed: 26521779
J Musculoskelet Neuronal Interact. 2003 Jun;3(2):176-84
pubmed: 15758359
J Bone Miner Res. 2010 Jul;25(7):1468-86
pubmed: 20533309
J Clin Invest. 2000 Oct;106(7):887-95
pubmed: 11018077
N Engl J Med. 2006 May 25;354(21):2250-61
pubmed: 16723616
Osteoarthritis Cartilage. 2004 Sep;12(9):752-61
pubmed: 15325642
Clin Orthop Relat Res. 2006 Feb;443:273-9
pubmed: 16462451
J Orthop Translat. 2018 Dec 21;18:65-73
pubmed: 31508309
Am J Orthop (Belle Mead NJ). 2004 Jul;33(7):327-32
pubmed: 15344574
Cell Mol Life Sci. 2017 Dec;74(24):4443-4453
pubmed: 28674727
J Bone Joint Surg Am. 2004 Nov;86(11):2471-4
pubmed: 15523020
Alcohol. 2016 Aug;54:27-32
pubmed: 27565753
Arch Bone Jt Surg. 2015 Jul;3(3):149-55
pubmed: 26213697
Osteoporos Int. 2005 Nov;16(11):1307-14
pubmed: 15999292
J Orthop Translat. 2020 Jan 06;21:100-110
pubmed: 32309135
J Arthroplasty. 2019 Jan;34(1):169-174.e1
pubmed: 30348559
J Autoimmun. 2020 Jun;110:102460
pubmed: 32307211
J Arthroplasty. 2001 Sep;16(6):790-4
pubmed: 11547379
J Arthroplasty. 2020 Aug;35(8):2286-2295
pubmed: 32376165
J Am Acad Orthop Surg. 1999 Jul-Aug;7(4):250-61
pubmed: 10434079
Osteoarthritis Cartilage. 2011 Feb;19(2):180-5
pubmed: 21087677
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2018 Jul 1;32(7):866-872
pubmed: 30129310
J Bone Joint Surg Br. 2001 Apr;83(3):419-22
pubmed: 11341431
Chin Med J (Engl). 2012 Jan;125(1):134-9
pubmed: 22340480
Bone Joint Res. 2021 Sep;10(9):571-573
pubmed: 34470462
Curr Rev Musculoskelet Med. 2015 Sep;8(3):201-9
pubmed: 26142896
J Arthroplasty. 2019 Jan;34(1):163-168.e1
pubmed: 30348552
Bone. 2013 Sep;56(1):139-46
pubmed: 23748104
Arch Orthop Trauma Surg. 2014 Jan;134(1):103-12
pubmed: 24248422
Biochem Biophys Res Commun. 2014 Sep 5;451(4):473-9
pubmed: 25078627
Clin Orthop Relat Res. 1979 Mar-Apr;(139):283-312
pubmed: 455846
Osteoporos Int. 2010 Sep;21(9):1553-64
pubmed: 19859642
Bone Joint Res. 2021 Sep;10(9):619-628
pubmed: 34569806
Joint Bone Spine. 2020 Jan;87(1):75-80
pubmed: 31521791
Bone Joint J. 2013 Mar;95-B(3):320-5
pubmed: 23450014
Biomed Pharmacother. 2018 Jan;97:825-832
pubmed: 29136757
J Orthop Translat. 2021 Aug 16;32:28-40
pubmed: 35591937
Osteoarthritis Cartilage. 1998 Nov;6(6):377-82
pubmed: 10343770
J Orthop Sci. 2002;7(5):601-5
pubmed: 12355139
Clin Biomech (Bristol, Avon). 2011 Jul;26(6):632-9
pubmed: 21353732
PLoS One. 2014 May 06;9(5):e96361
pubmed: 24800992
Alcohol Alcohol. 2003 Sep-Oct;38(5):431-6
pubmed: 12915519
N Engl J Med. 2011 Jul 7;365(1):62-70
pubmed: 21732837
Orthopedics. 2014 Jan;37(1):e24-8
pubmed: 24683652
J Arthroplasty. 1996 Apr;11(3):267-71
pubmed: 8713904
Clin Orthop Relat Res. 1999 Nov;(368):149-61
pubmed: 10613163
Osteoarthritis Cartilage. 2014 Dec;22(12):2083-92
pubmed: 25205016
Clin Orthop Relat Res. 2003 May;(410):213-24
pubmed: 12771833
Arthritis. 2012;2012:601763
pubmed: 23243507
Bone. 2015 Aug;77:91-7
pubmed: 25892484
Int J Clin Exp Pathol. 2013 May 15;6(6):1046-50
pubmed: 23696921
Int Orthop. 2019 May;43(5):1089-1095
pubmed: 29916002
J Cell Signal. 2020;1(3):42-49
pubmed: 32728672
Microsc Res Tech. 1997 May 15;37(4):343-57
pubmed: 9185156
J Bone Joint Surg Am. 2015 Oct 7;97(19):1604-27
pubmed: 26446969
J Endocrinol Invest. 2004 Jan;27(1):99-105
pubmed: 15053252
Alcohol Clin Exp Res. 2019 Dec;43(12):2494-2503
pubmed: 31557335
Bone Joint Res. 2021 Aug;10(8):488-497
pubmed: 34346256
Bone. 2005 Jul;37(1):1-9
pubmed: 15894527